Skip to main content

Featured

Tax Deadline April 30: The Most Common CRA Mistakes Canadians Make — and How to Avoid Them

Missed deductions, wrong SINs, unreported side income — these are the errors that delay your refund, trigger CRA letters, and quietly cost Canadians millions every year. Here's your 2026 checklist With April 30 just days away, millions of Canadians are racing to pull together slips, receipts, and records before the Canada Revenue Agency's personal income tax deadline. But filing on time and filing  correctly  are two very different things. The CRA flags thousands of returns each year for errors that are entirely preventable — errors that delay refunds, generate costly reassessments, and sometimes result in penalties that linger for months. Whether you're a first-time filer, a seasoned DIY-er, or someone handing everything to an accountant, here are the 10 most common CRA mistakes Canadians make — and exactly how to avoid each one. 1. Misunderstanding the April 30 deadline The filing deadline for most Canadians is  April 30, 2026 . Miss it when you owe money, and you'll ...
Post a Comment
Read more

article

Labels

Revolutionary Gene Therapy Restores Hearing in Deaf Toddler

 

In a remarkable medical breakthrough, an 18-month-old toddler named Opal Sandy has regained her hearing thanks to a pioneering gene therapy trial. Born deaf due to a rare genetic condition affecting the OTOF gene, which is responsible for producing a protein essential for hearing, Opal’s prospects for natural hearing were bleak. However, the innovative treatment at Cambridge University Hospitals in England has opened up a world of sound for her.

The procedure involved the infusion of a working copy of the OTOF gene into Opal’s right ear, a process that took a mere 16 minutes. Remarkably, within weeks, Opal began responding to loud noises, and after 24 weeks, she could hear whispers, indicating a near-normal level of hearing restoration.

Opal’s case is part of the Chord trial, which is recruiting more children from the UK, Spain, and the US to undergo similar treatment. The trial is being closely monitored, with participants followed up for five years to assess the long-term efficacy and safety of the therapy.

The success of this gene therapy is a beacon of hope for many suffering from genetic deafness, signaling the dawn of a new era in medical science where conditions once thought incurable are now within the realm of treatment. Opal’s story is not just a personal victory; it’s a milestone in genetic medicine, showcasing the incredible potential of gene therapy to change lives.

Labels:

Comments

Post a Comment